MBRX
Moleculin Biotech, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website moleculin.com
- Employees(FY) 15
- ISIN US60855D3098
Performance
+6.28%
1W
+18.69%
1M
-31.93%
3M
-44.57%
6M
-60.55%
YTD
-46.88%
1Y
Profile
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066 that is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. It is also developing WP1220, an analog of WP1066 for the topical treatment of cutaneous T-cell lymphoma; and WP1122 to treat glioblastoma multiforme and COVID-19. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Technical Analysis of MBRX 2024-05-10
Overview:
In analyzing the technical indicators for MBRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-05-15 20:32
- 2024-05-15 18:22
- 2024-05-14 20:38
- 2024-05-13 15:00
- 2024-05-12 19:30
- 2024-05-10 09:52
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024(Investorplace)
- 2024-05-08 20:30
- 2024-05-07 20:45
- 2024-05-06 20:55
- 2024-05-01 21:00
- 2024-04-30 20:50
- 2024-04-24 21:45
- 2024-04-17 20:30
- 2024-04-09 20:30
- 2024-03-27 22:45
- 2024-03-26 21:25
- 2024-03-26 21:05
- 2024-03-25 20:36
- 2024-03-24 19:30
- 2024-03-22 08:52
- 2024-03-22 05:31
- 2024-03-22 04:05
- 2024-03-19 19:30
- 2024-03-19 04:30
Moleculin Announces Reverse Stock Split(Prnewswire)
- 2024-03-11 21:05
- 2024-01-23 19:50
- 2023-12-20 08:16
- 2023-12-10 19:50
- 2023-11-14 00:46
- 2023-11-13 21:29
Page 1 of 5
previousnext